The Fellow on Call: The Heme/Onc Podcast
The Fellow on Call: The Heme/Onc Podcast is dedicated to bringing its listeners the fundamentals, core concepts, and important management approaches in the field of hematology and oncology, driven by the latest evidence and expert opinion. In each episode, the hosts provide answers to common questions in a way that is perfect for anyone interested in hematology and oncology, from students and trainees to nurses, advanced practice providers, and practicing physicians.
Advertisement
The group kicks off a new series on DLBCL, starting with the basics that come before disease management.
The Fellow on Call group characterizes HIT, discusses the risk factors for HIT antibody formation, and much more.
The Fellow on Call Podcast team shifts their focus from types 1 and 3 vWD to type 2 subtypes and how to manage them.
The Fellow on Call team continues their series on hematology consultation with an overview of von Willebrand disease.
Kaele Leonard, a pulmonary/critical care fellow who was diagnosed with breast cancer at a young age, discusses her journey.
The Fellow on Call: The Heme/Onc Podcast covers HER2-positive breast cancer in part 11 of its series on breast cancer types.
The Fellow on Call: The Heme/Onc Podcast switches from localized breast cancers to metastatic subtypes, starting with ER+.
The Fellow on Call Podcast shifts its breast cancer focus to the triple-negative subtype.
The Fellow on Call Podcast shifts their focus from ER+ to HER+ breast cancer, detailing treatment options, and much more.
The Fellow on Call group continues discussing the management of early stage ER+/HER2-breast cancer.
Part one of a two-part discussion on early stage ER+/HER2- breast cancer.
Dr. Danielle Roman joins The Fellow on Call group to discuss pharmacology advancements in breast cancer.
Dr. Carla Fisher details the nuances of surgical management for breast cancer.
The Fellow on Call group clarifies the many complicated terms used in breast cancer.
Radiation oncology resident Dr. Ryan Miller discusses the critical role of radiation therapy in breast cancer management.
Dr. Yasha Gupta joins the group to elucidate the role breast radiologists play in diagnosing and treating this malignancy.
The group makes the distinction between non-small cell lung cancer, used as an umbrella term, and small cell lung cancer.
Drs. Matthew Abrahamson, Timothy Yau, and Scott Stockholm discuss immune checkpoint inhibitor-related acute kidney injuries.
Lung cancer is one of the most common and deadly malignancies found in oncology, making early detection critical.
The third episode in this series answers: What do you do when performing a biopsy on a suspected metastatic lesion?
The group continues their discussion with the esteemed Dr. Jack West from City of Hope.
Dr. Jane Yanagawa explains the importance of preoperative workup, the meaning and function of "VATS," and more.
Treating a patient with widespread mNSCLC presents a very different challenge than treating one without distant disease.
What's the best approach for treating metastatic non-small cell lung cancers that possess certain mutations?
Dr. Jack West of City of Hope shares his thoughts on the ADAURA Trial, IMPOWER010, and CHECKMATE816.
How do you diagnose thrombotic thrombocytopenic purpura? The group points out clinical presentations.
The group kicks off their cytopenias journey by delineating their approach for managing thrombocytopenia.
This episode of The Fellow on Call: The Heme/Onc Podcast rounds out the cytopenias series.
In this episode of The Fellow on Call: The Heme/Onc Podcast: How to manage the dangerous occurrence of brain metastasis?
In this episode of The Fellow on Call: The Heme/Onc Podcast, the group closes out their hemophilia series.
The group delineates the acute management of hemophilia patients, particularly with factor replacement.
The group distinguishes between the two types of hemophilia: genetic and acquired.
The team starts their hemophilia series by discussing the nuances of evaluating a patient with a suspected bleeding disorder.
Your hosts continue their journey through the realm of cytopenias.
The group continues their analysis of emergencies by exploring immune thrombocytopenic purpura.
According to group, whenever a patient with heparin exposure has a new thrombotic event, you should consider HIT.
The group discusses the goals of induction therapies, treatment combinations for neoadjuvant lung cancer therapy, and more.
The trio continue their discussion with radiation oncologist Dr. Evan Osmundson on everything pertaining to radiation.
The team is joined by Evan Osmundson, MD, PhD, to speak about the fundamentals of radiation oncology.
The group stresses the importance of approaching every case in a stepwise fashion.
Advertisement
DocWire News delivers the latest medical industry news, giving health care professionals the curated content most relevant to their fields and practices.
Get the latest updates from DocWire News experts, including The Fellow on Call.
